Pricing Log in Create free account
Friday 6 November 2026 Export AXGN’s income statement to Excel — free account

AxoGen, Inc.

AXGN Healthcare Medical Devices

AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.

Revenue
+26.2%
EPS
+163.2%
Free cash flow
+995.0%
Total debt
−73.1%

Quarter to September 2026, against a year earlier

49.43 0.68 +1.39%
Market cap
$2.9B
P/E
0.0×
Fwd P/E
−129×
Dividend yield
—
F-score
5/9
Altman Z
9.23
Beneish M
−2.73
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

AxoGen, Inc. (AXGN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, AxoGen, Inc. (AXGN) trades at a P/B ratio of 5.4×. Over the past ten years it has ranged from 0.0× (September 2015) to 250× (October 2016); the current reading is higher than 47% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 11.7× 66.65%
FY2024 7.0× 126.64%
FY2023 3.1× (24.76%)
FY2022 4.1× 19.98%
FY2021 3.4× (40.94%)
FY2020 5.8× 9.37%
FY2019 5.3× 2.92%
FY2018 5.2× (86.05%)
FY2017 37.0× 101.97%
FY2016 18.3× 15.11%

Quarterly newest first

Period P/B ratio Change
Sep 2026 4.7× (51.52%)
Jun 2026 9.6× 37.70%
Mar 2026 7.0× (40.31%)
Dec 2025 11.7× 70.37%
43 more quarters

Against its own ten years

Low 0.0× High 250×
Ten-year median 5.7×
Current reading's percentile 45

P/B ratio against peers

Company P/B ratio
NEOG Neogen Corporation compare 1.2×
INSP Inspire Medical Systems, Inc. compare 2.3×
ITGR Integer Holdings Corporation compare 2.5×
TMDX TransMedics Group, Inc. compare 4.3×
UFPT UFP Technologies, Inc. compare 5.0×
AXGN AxoGen, Inc. 5.4×
ALMR Alamar Biosciences, Inc. compare 6.2×
IRTC iRhythm Holdings, Inc. compare 24.4×
ESTA Establishment Labs Holdings Inc. compare 89.6×
Medical Devices industry median 2.5×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on AXGN